Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase II trial of two different first-line chemotherapy sequences in advanced non small cell lung cancer
2008-005967-33Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria delle Marche
- Start
- Mar 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of docetaxel, cisplatin and gemcitabine in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Azienda Ospedaliero-Universitaria delle Marche. Primary endpoint: progression percentage. Started Mar 2009; status: active.
02
Drugs
docetaxelcisplatingemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2008-005967-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005967-33.